Bradley Foster & Sargent’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,362
Closed -$616K 469
2021
Q4
$616K Sell
12,362
-2,980
-19% -$157K 0.01% 306
2021
Q3
$706K Sell
15,342
-56
-0.4% -$2.22K 0.02% 266
2021
Q2
$461K Buy
+15,398
New +$314K 0.01% 315

Other funds holding ASPN

Bradley Foster & Sargent's ASPN Position: Q1 2022 in Review

Bradley Foster & Sargent sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 12,362 shares — an estimated $616K sold.

Bradley Foster & Sargent first reported a position in ASPN in Q2 2021 and held it in 3 quarters. The position peaked at $706K in Q3 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

  • Bradley Foster & Sargent reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
  • Bradley Foster & Sargent sold 12,362 Aspen Aerogels shares in Q1 2022, an estimated $616K.
  • Bradley Foster & Sargent first reported a position in Aspen Aerogels in Q2 2021 and held it in 3 quarters.
  • Bradley Foster & Sargent's Aspen Aerogels position peaked at $706K in Q3 2021.
  • 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on Bradley Foster & Sargent's 13F filing for Q1 2022, filed 16 May 2022.